India may go to WTO over EU’s drug suspension order of 700 generics
India is examining whether to take up with WTO the EU’s suspension order for sale of about 700 generic drugs which were approved…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Janssen India launches Invokana to treat type II diabetes
Invokana belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors
Zydus to tie up with US-based research centre
To develop a vaccine against visceral leishmaniasis
Hilleman Laboratories to extend its thermostable formulations to other vaccines
The company plans to support India’s aim of achieving 90 per cent coverage through its expanded programme by 2020
PEL to acquire majority equity stake in Health SuperHiway
The investment will be made in two tranches
IPM clocks Rs 7389 crores in March 2015
Eight therapies have outgrown the IPM growth and all therapies have double digit growths
Pharma EM issues not as straightforward: Experts
Conference attended by regulatory affairs experts and pharma companies
‘Our goal is for all United Nations members to sign up an agreement on policies to deal with…
As the Obama administration chalks out a plan to combat the growing menace of antibiotic resistance, Jim ‘o’ Neill who was…
Cabinet clears Rs 4,187-crore Glenmark, Aurobindo proposals
The decision was taken by CCEA, chaired by Prime Minister Narendra Modi
DRL, Promius Pharma files NDAs with US FDA
Dr Reddy’s Laboratories and its subsidiary, Promius Pharma announced the filing of three 505(b)(2) New Drug Applications (NDAs)…
Indoco acquires Piramal’s clinical research division
This facility is spread across an area of 30,000 sq ft and is equipped with a 98-bed facility
Sangh Parivar affiliate pans draft IPR policy
Don’t dilute Patent Act, blogs Swadeshi Jagaran Manch co-convenor
Drugs to cost just 20-30 per cent of price at Jan Aushadhi stores
The generic drugs that would be made available at ‘Jan Aushadhi’ stores across the country would be made available at 20-30 per…
Happy of government’s proactive support: GVK BIO CEO
Commerce Secy may take the GVK BIO case to WTO
IPGA, RDCA organise public awareness programme
More than 250 retailers and distributors of NCT Delhi were invited to participate in the session
US FDA, DCG(I) explore more ways to work together
Willing to collaborate with Indian regulators, other stakeholders: US FDA
SC stays Delhi HC order against Glenmark
Company can make, sell its brands of MSD's diabetes products till April 28
End of Wockhardt’s Chikalthana USFDA woes?
No major findings from recent USFDA inspection, after 2013 import alert on the company's Aurangabad-based Waluj and Chikalthana…
Sun Pharma closes merger deal with Ranbaxy
The combined entity’s manufacturing footprint covers five continents with products sold in over 150 nations